View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
DOJ/DEA | RIN: 1117-AB17 | Publication ID: Fall 2009 |
Title: Classification of Three Steroids as Schedule III Anabolic Steroids Under the Controlled Substances Act | |
Abstract: This rule classifies the following three steroids as “anabolic steroids” under the Controlled Substances Act (CSA): Boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione. The Drug Enforcement Administration (DEA) believes that this action is necessary in order to prevent the abuse and trafficking of these steroids. | |
Agency: Department of Justice(DOJ) | Priority: Other Significant |
RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Final Rule Stage |
Major: No | Unfunded Mandates: No |
CFR Citation: 21 CFR 1300 | |
Legal Authority: 21 USC 802 21 USC 871 (b) 21 USC 951 21 USC 958(f) |
Legal Deadline:
None |
||||||||||||
Timetable:
|
Additional Information: Docket Number DEA-285 | |
Regulatory Flexibility Analysis Required: No | Government Levels Affected: None |
Small Entities Affected: No | Federalism: No |
Included in the Regulatory Plan: No | |
RIN Data Printed in the FR: No | |
Agency Contact: Christine A. Sannerud Ph.D. Chief, Drug and Chemical Evaluation Section, Office of Diversion Control Department of Justice Drug Enforcement Administration 8701 Morrissette Drive, Washington, DC 20537 Phone:202 307-7183 |